Terri B. Sebree, President at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 8,281 shares at $1.10 ($9K) on 2022-07-19, disclosed to the SEC on 2022-07-20.
Open-market sale of $9k ZYNE by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZYNE | BUY | 2018-08-07 | $22K | — | Filing → |